Brief: Haemato 9-Month Revenues Up At EUR 216.6 Mln
18/11/2021 06:07
Nov 18 (Reuters) - HAEMATO AG HAEk.DE :
* REPORTS FIGURES FOR THE 3RD QUARTER OF 2021: FURTHER
INCREASE IN
REVENUE AND EARNINGS AS WELL AS CONFIRMATION OF REVENUE AND
EARNINGS EXPECTATIONS FOR 2021
* Q3 EBIT 1.4 MILLION EUR
* FORECAST FOR CURRENT FINANCIAL YEAR IS CONFIRMED. FOR
2021,
CONSOLIDATED SALES OF 280 MILLION TO 300 MILLION EUROS AND EBIT
OF 9 MILLION TO 11 MILLION EUROS ARE STILL EXPECTED
* FOR FIRST NINE MONTHS OF 2021, GROUP EBITDA INCREASED FROM
3.1
MILLION EUROS (PREVIOUS YEAR) TO 9.7 MILLION EUROS
* 9-MONTH REVENUES TOTALLED 216.6 MILLION EUROS (PREVIOUS
YEAR:
175.6 MILLION EUROS)
* 9-MONTH EBIT MARGIN ROSE DISPROPORTIONATELY FROM 1.0% TO
4.0%
Source text for Eikon: ID:nEQ4nxxyba
Further company coverage: HAEk.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Haemato AG
See all newsBrief: HAEMATO Raises FY EBIT Guidance to EUR 10-12 Million
Brief: Haemato Says Terminates Cooperation With Korean Manufacturer Huons Biopharma; To Discontinue Project For A Proprietary Botulinum Toxin
Brief: Haemato Q1 EBITDA At EUR 2.3 Mln
Brief: Haemato To Propose Dividend Of EUR 1.10 Per Share
Brief: Haemato Preliminary Consolidated FY EBIT Up At EUR 11.2 Mln